Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone
Condition(s):Healthy Subjects; Opioid Antagonist; PharmacokineticsLast Updated:July 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Healthy Subjects; Opioid Antagonist; PharmacokineticsLast Updated:July 15, 2022Completed
Condition(s):Brain Death; Organ Donors; Lung TransplantationLast Updated:July 31, 2020Completed
Condition(s):Overdose; Risk BehaviorLast Updated:August 24, 2023Active, not recruiting
Condition(s):Opioid-use DisorderLast Updated:February 29, 2024Recruiting
Condition(s):Pathological Gambling; Gambling Disorder; Opioid Antagonist; NaloxoneLast Updated:July 16, 2019Unknown status
Condition(s):Gambling; Opioid; Naloxone; SprayLast Updated:September 12, 2019Completed
Condition(s):Hypoglycemia Unawareness; Type 1 DiabetesLast Updated:March 27, 2023Terminated
Condition(s):Medication Abuse; Harm ReductionLast Updated:February 29, 2024Not yet recruiting
Condition(s):Opioid OverdoseLast Updated:May 2, 2022Completed
Condition(s):Drug OverdoseLast Updated:October 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.